SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001628280-21-018245
Filing Date
2021-09-08
Accepted
2021-09-08 17:05:58
Documents
118
Period of Report
2021-06-30

Document Format Files

Seq Description Document Type Size
1 6-K nbx-20210630.htm   iXBRL 6-K 2866493
2 EX-99.2 nanobiotix-secxform6xk2021.htm EX-99.2 417069
  Complete submission text file 0001628280-21-018245.txt   15886719

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT nbx-20210630.xsd EX-101.SCH 119008
4 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT nbx-20210630_cal.xml EX-101.CAL 73811
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT nbx-20210630_def.xml EX-101.DEF 454024
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT nbx-20210630_lab.xml EX-101.LAB 871934
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT nbx-20210630_pre.xml EX-101.PRE 666995
8 EXTRACTED XBRL INSTANCE DOCUMENT nbx-20210630_htm.xml XML 3545008
Mailing Address 60 RUE DE WATTIGNIES PARIS I0 75012
Business Address 60 RUE DE WATTIGNIES PARIS I0 75012 33140260470
Nanobiotix S.A. (Filer) CIK: 0001760854 (see all company filings)

IRS No.: 000000000 | State of Incorp.: I0 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-39777 | Film No.: 211242816
SIC: 2834 Pharmaceutical Preparations